Brucellosis in pregnancy: a case report
- PMID: 39866268
- PMCID: PMC11760922
- DOI: 10.21037/acr-24-110
Brucellosis in pregnancy: a case report
Abstract
Background: Brucella spp., a gram-negative bacterium, is one of the most prevalent zoonotic illnesses worldwide and is more commonly seen in animals; however, the disease may be present in humans. Clinical manifestations of brucellosis are variable and can range from asymptomatic to severe disease. In women who are pregnant, potential obstetrics complications are possible. The purpose of this report is to present a case of brucellosis in a pregnant patient and discuss the potential complications and treatment recommendations.
Case description: We present a case of a 17-year-old gravida 2, parity 1 (G2P1) at 35 weeks and 2 days (35w2d) with brucellosis after she assisted in the delivery of puppies. All puppies were stillborn and the dog was confirmed positive for B. canis on serological testing. Our patient was also found to have B. canis, which is a particularly rare cause of human brucellosis. She was treated with ceftriaxone, rifampin, and gentamicin before delivery and switched to doxycycline and ceftriaxone postpartum until negative. The patient was instructed not to breastfeed. After treatment, the patient felt well and the baby was healthy.
Conclusions: When evaluating patients, it is necessary to obtain a social history including animal exposures to rule in or rule out zoonotic infections such as brucellosis. It is important to establish a suspected brucellosis infection in pregnancy and begin antibiotic treatment as soon as possible to prevent maternal and fetal complications. The treatment regimen we administered was an effective strategy, particularly for pregnancy, when typical treatments are contraindicated.
Keywords: Brucellosis; case report; dogs; pregnancy.
2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://acr.amegroups.com/article/view/10.21037/acr-24-110/coif). S.A. reports that this manuscript was funded by the Department of OBGYN and Infectious Disease at UMMC. The other authors have no conflicts of interest to declare.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 23, 2023 (Week 51). Centers for Disease Control and Prevention. Accessed July 3, 2024. Available online: https://wonder.cdc.gov//nndss/static/2023/51/2023-51-table340.html
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous